(Total Views: 332)
Posted On: 01/11/2018 3:25:55 PM
Post# of 11803
Even though this was a little while ago 12/13/17, I thought it was interesting and wanted to share. IMO.
https://globenewswire.com/news-release/2017/1...-2022.html
from the article.
Companies mentioned in this report include Abbott Labs, Apple, Ascensia Diabetes Care Holdings, Cellnovo Group, Debiotech, Echo Therapeutics, Glooko, Insulet, Johnson & Johnson, Labstyle Innovations, Medella Health, Medtronic, Nemaura Medical, Novo Nordisk, Onduo, Pharma Tech Solutions, Roche, Sanofi, Tandem Diabetes Care, Unilife and Ypsomed, among others.
GLTA!
https://globenewswire.com/news-release/2017/1...-2022.html
from the article.
Companies mentioned in this report include Abbott Labs, Apple, Ascensia Diabetes Care Holdings, Cellnovo Group, Debiotech, Echo Therapeutics, Glooko, Insulet, Johnson & Johnson, Labstyle Innovations, Medella Health, Medtronic, Nemaura Medical, Novo Nordisk, Onduo, Pharma Tech Solutions, Roche, Sanofi, Tandem Diabetes Care, Unilife and Ypsomed, among others.
GLTA!
(0)
(0)
